BeOne Medicines Ltd. (HKG:6160)

BeOne Medicines Revenue

BeOne Medicines had revenue of 8.11B CNY in the quarter ending March 31, 2025, with 49.38% growth. This brings the company's revenue in the last twelve months to 30.30B, up 51.91% year-over-year. In the year 2024, BeOne Medicines had annual revenue of 27.81B with 59.51% growth.

• Revenue (ttm): 30.30B CNY
• Revenue Growth: +51.91%
• P/S Ratio: 8.30
• Revenue / Employee: 2.75M CNY
• Employees: 11,000
• Market Cap: 269.70B HKD

Revenue Chart

* This company reports financials in CNY.

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2024	27.81B	10.38B	59.51%
Dec 31, 2023	17.43B	7.67B	78.53%
Dec 31, 2022	9.77B	2.29B	30.69%
Dec 31, 2021	7.47B	5.46B	270.56%
Dec 31, 2020	2.02B	-965.08M	-32.37%